B cells and plasma cells were found to co-present in TLS, and the abundance of intra-tumoral B cells was also linked to the prediction in the response efficacy of anti-PD-L1 in NSCLC (101, 102). This evidence concerns the gene CD274 and non-small cell lung carcinoma.